mesothelin expression testing

DEVICE2 trials

Sponsors

University of Pennsylvania, National Cancer Institute (NCI)

Conditions

Breast CancerColonic NeoplasmsLung NeoplasmsMesotheliomaNeoplasmsOvarian NeoplasmsPancreatic NeoplasmsStomach Neoplasms

Phase 1

CAR T Cells in Mesothelin-Expressing Breast Cancer

TerminatedNCT05623488

University of PennsylvaniaBreast Cancer

Start: 2023-02-06End: 2025-04-07Updated: 2025-08-12

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

RecruitingNCT06885697

National Cancer Institute (NCI)Colonic Neoplasms, Lung Neoplasms, Mesothelioma +5

Start: 2025-07-08End: 2044-06-01Target: 100Updated: 2026-08-26